Startups·29 May 2026·via Pr Newswire Apac
XtalPi Receives Second Payment from DoveTree; First Oncology Asset Advances into IND-Enabling Studies
BOSTON , May 29, 2026 /PRNewswire/ -- XtalPi (2228. HK), an AI- and robotics- powered drug discovery platform, announced that its strategic collaboration with innovative biopharmaceutical company DoveTree Medicines Unus Inc.
Share this article
Original reporting by Pr Newswire ApacWe don't republish, read the full story →
Related reading
6 stories
🇮🇳·Startups
Quad Foreign Ministers Meet In Atlanta, Agree To Expand Joint Exercises And Maritime Surveillance
🇸🇬·Startups
Rare, roomy and pricey? Inside Singapore's niche jumbo HDB flat market
🇮🇳·Startups
Sanjay Gupta’s Last Rites Held In Mumbai, Abhishek Bachchan, Rakesh Roshan Pay Last Respects
🇮🇳·Startups
EVE NET Turns Spare Smartphone Capacity Into An AI Cloud
🇮🇳·Startups
Telangana Neta Natter | A Busload Of Trouble For Congress’s Delhi March
🇮🇳·Startups